Two 21-year old dizygotic twin men of Iraqi descent were homozygous for HBB codon 8, deletion of two nucleotides (-AA) frame-shift b 0 -thalassaemia mutation (FSC8; HBB:c25_26delAA). Both were clinically well, had splenomegaly, and were never transfused. They had mild microcytic anaemia (Hb 120-130 g/l) and 98% of their haemoglobin was fetal haemoglobin (HbF). Both were carriers of Hph a-thalassaemia mutation. On the three major HbF quantitative trait loci (QTL), the twins were homozygous for G>A HBG2 Xmn1 site at single nucleotide polymorphism (SNP) rs7482144, homozygous for 3-bp deletion HBS1L-MYB intergenic polymorphism (HMIP) at rs66650371, and heterozygous for the A>C BCL11A intron 2 polymorphism at rs766432. These findings were compared with those found in 22 other FSC8 homozygote patients: four presented with thalassaemia intermedia phenotype, and 18 were transfusion dependent. The inheritance of homozygosity for HMIP 3-bp deletion at rs66650371 and heterozygosity for Hph a-thalassaemia mutation was found in the twins and not found in any of the other 22 patients. Further studies are needed to uncover likely additional genetic variants that could contribute to the exceptionally high HbF levels and mild phenotype in these twins.
Patients who are either homozygous or compound heterozygous for b-thalassaemia mutations have intracellular accumulation of free HbA that precipitates and leads to erythroid cell apoptosis, ineffective erythropoiesis and haemolysis. Most of these patients are severely anaemic from an early age and require chronic red blood cell (RBC) transfusions (Weatherall & Clegg, 2001) .
Increased HbF production is found in adults with hereditary persistence of fetal haemoglobin (HPFH) point mutations in HBG promoters or with HPFH, (HBD HBB) 0 -or (HBG1 HBD HBB) 0 -thalassaemia deletions. In addition, three major HbF quantitative trait loci (QTL) mediate increased HbF production (Thein & Menzel, 2009 ). They are defined by the HBG2 Xmn1 polymorphism at Chr11p15 (rs7482144), the HBS1L-MYB intergenic polymorphism (HMIP) at 6q23 (rs66650371) and the BCL11A intron 2 polymorphism at 2p16 (rs766432). Their alternate or minor alleles are associated with elevated HbF levels. Two dizygotic twin young men were homozygous for FSC8 mutation (HBB:c25_26delAA). Both were clinically well, had mild microcytic anaemia and almost all haemoglobin produced was HbF. In contrast, among 22 other FSC8 homozygote patients, four had thalassaemia intermedia phenotype and 18 were transfusion dependent. We now report genetic determinants found in both twins pertaining to their capacity to produce large amounts of HbF. Further studies are needed to uncover likely additional genetic variants that can up-regulate HbF expression in these patients.
Methods

Haematological analyses
Blood counts were done using an automated haematology analyser. Haemoglobin analyses were carried out with Variant II cation high-performance liquid chromatography (HPLC) system (Bio-Rad, Hercules, CA, USA).
Molecular diagnoses
Genomic DNA was extracted from peripheral blood leucocytes by QIAGEN BioRobot EZ1 workstation with EZ1 DNA kit (Qiagen, Valencia, CA, USA). Globin genes and other genetic loci of interest were amplified by polymerase chain reaction (PCR), and the purified amplicons were subjected to Sanger bidirectional nucleotide sequencing using the ABI Big Dye Terminator Cycle Sequencing kit (Applied BioSystems, Foster City, CA, USA) and ABI 3730 DNA Analyser. HBA deletions were assessed by gap-PCR (Tan et al, 2001) .
Sentinel single nucleotide polymorphisms (SNPs), rs66650371, rs9399137 and rs766432 in known HbF QTL were determined by PCR-based amplification refractory mutation system (ARMS) (Farrell et al, 2011; Table SI) .
Multiplex ligation-dependent probe amplification (MLPA) analysis was done on the HBB gene cluster including its locus control region (LCR) using the SALSA MLPA KIT P102 HBB kit (MRC Holland, Amsterdam, the Netherlands) according to manufacturer's instructions.
Haplotype analysis of the HBB globin gene cluster
The haplotype of the HBB globin gene cluster found in Mediterranean populations as described by Orkin et al (1982) was determined by the polymorphic profile of seven restriction sites (HBE-HindII, HBG2-HindIII, HBG1-HindIII, 5 0 and 3 0 HBBP1-HindII, HBB-AvaII and HBB-HinfI) using PCR-restriction fragment length polymorphism procedures as previously described (Ekwattanakit et al, 2012) .
Results
Case report and family study
A 21-year old Iraqi-American man was found to have splenomegaly. He was otherwise well, and had never been transfused. He had mild microcytic anaemia (Hb 123 g/l; MCV (Table I) . Matrix-assisted laser desorption ionization (MALDI) mass spectrometry revealed the proportion of HBG2/HBG1 at approximately 3/1 to 4/1, and HBE was not detected (data not shown). Nucleotide sequencing of his HBB, HBA2, HBA1, HBG2 and HBG1 was done. The patient was homozygous for FSC8 b 0 -thalassaemia mutation ( Fig   S1A) , heterozygous for Hph a-thalassaemia mutation in his HBA2 (HBA2:c.95 + 2_95 + 6delTGAGG), and homozygous for the G>A HBG2 promoter Xmn1 polymorphism at rs7482144 (HBG2:c.-211G>A). Known HPFH mutations were not found in his HBG2 and HBG1 promoters. There was no deletion or duplication involving his HBB locus, as shown by MLPA (Fig S1B) . His KLF1 gene was sequenced, and no mutation was found (data not shown). The proband had a dizygotic twin brother, documented by non-identical SNP genotypes at 7 different loci on chromosomes 7, 13, 16 and 19 (Table SII) . Table I tabulates the clinical laboratory results of the proband, his dizygotic twin brother, his older sister and both his parents. The other twin also was homozygous for FSC8 mutation, and their sister and parents were heterozygous for the same mutation.
Both twins were homozygous for HBB cluster haplotype IV, which is found in only 1% of the Mediterranean population (Orkin et al, 1982) . Except for HBB-AvaII polymorphism, haplotype IV is identical to Senegal haplotype found in sickle cell anaemia patients who have relatively high HbF levels (Akinsheye et al, 2011) . The twins' parents and sister had haplotypes I/IV.
HBB cluster locus
HBB locus control region (LCR) DNase I hypersensitive site 2 (HS2) core in the proband was sequenced from Chr11:5 301 778-5 302 235. No mutation or deletion was found. He had identical purine/pyrimidine repetitive sequences [(TA) 9 (CA) 2 (TA) 2 CG (TA) 10 ] downstream of LCR HS2 core as in sickle cell anaemia patients with Senegal haplotype ( € Oner et al, 1992) . Within the HBD-HBG1 intergenic region, there are multiple cis-regulatory elements capable of modulating HBG expression (Fig S2) . Overlapping amplicons covering the entire 14Á5 kb intergenic region in the proband were obtained by PCR, and Sanger nucleotide sequencing was done. No deletion was found. The twin was homozygous for alternate alleles of rs10128556 and rs2071348 (Table II, Fig  S2) , which were previously shown to be associated with increased HbF in sickle cell anaemia patients and in patients with HbE/b 0 -thalassaemia mutation, respectively (Galarneau et al, 2010; Nuinoon et al, 2010) . He was homozygous for the alternate alleles of 19 SNPs, none of which resides within known functional motifs ( Fig S2 , Table SIII ). The transcription factor BP1 (DLX4) binding site at 530 bp 5 0 to the HBB in the proband was found to be homozygous for the common reference sequence, [(AC) 2 (AT) 7 T 7 ] (Zoueva et al, 2008) .
HbF quantitative trait loci (QTL)
XmnI polymorphism in the HBG2 promoter on Chr. 11p15. Both twins were homozygous for the alternate allele A at rs7482144, also known as the XmnI polymorphism at nt -158 in the HBG2 promoter (Table II) . HMIP polymorphism on Chr. 6q23. Both twins and their three other immediate family members were homozygous for the alternate allele C at the sentinel SNP rs9399137 in HMIP (Table II) . Furthermore, all five family members were homozygous for the 3-bp deletion, rs66650371, which is in linkage disequilibrium with rs9399137 and primarily responsible for mediating this QTL's effect upon HbF expression (Farrell et al, 2011; Stadhouders et al, 2014) .
BCL11A intron 2 polymorphism on Chr. 2p16. Both twins and their father were heterozygous for the alternate allele of BCL11A intronic SNP rs766432 (Table II) (Menzel et al, 2007a) . There are three erythroid specific DNase I hypersensitive sites (DHS) within BCL11A intron 2, known as +55, +58 and +62 based on the distances in kb between the DHS motif and BCL11A transcription start site (Fig 1) (Bauer et al, 2013) . The three DHS sites in the proband were sequenced. The proband was found to be heterozygous for alternate alleles among three other SNPs located within DHS +62 and +55, rs1427407, rs1896293 and rs7606173, all known to be associated with elevated HbF levels in sickle cell anaemia patients (Fig 1, Table II ) (Bauer et al, 2013) .
Other FSC8 homozygote patients can/Algerian). Ten had undergone splenectomy. Fifteen of these transfusion dependent patients were homozygous for HBB cluster haplotype IV/IV, and homozygous for XmnI polymorphism in the HBG2 promoter, identical to that found in the asymptomatic twins. Three other patients, 1 Turkish and 2 North African, were homozygous for haplotype VII/VII, and they did not have the XmnI polymorphism in their HBG2 promoter. Table III summarizes the HbF QTL findings among all FSC8 homozygotes. Both dizygotic twins were homozygous for the 3-bp deletion at rs66650371 in HMIP (Table II) . Among the four patients with "mild" phenotype, three were heterozygous for the 3-bp deletion, and 1 did not have the deletion (Table SIV) . Among the 18 transfusiondependent patients, eight were heterozygous for the 3-bp deletion, and the other 10 did not have the deletion (Table SV ). The differences in the allele frequencies among these three groups of patients are statistically highly significant (P = 0Á0035).
Discussion
The FSC8 b 0 -thalassaemia mutation (HBB:c25_26delAA) was first described in a Turkish patient (Orkin & Goff, 1981) . This deletion leads to a premature termination codon TGA at codon 21 upstream of the first exon-intron junction. The aberrant HBB mRNA transcripts are subjected to nonsensemediated decay resulting in b 0 -thalassaemia. Homozygotes for this mutation usually are transfusion-dependent, and are found in Turkey, Northern Iraq, Azerbaijan, Morocco, and their neighbouring regions (Gurgey et al, 1989; C€ ur€ uk et al, 1992; Kuliev et al, 1994; Lemsaddek et al, 2003 Lemsaddek et al, , 2004 Al-Allawi et al, 2010; Hamamy & Al-Allawi, 2013) . Gurgey et al (1989) reported 8 Turkish patients homozygous for FSC8 mutation who presented as thalassaemia The dizygotic twins in this report were homozygous for the FSC8 mutation. Their phenotype was the mildest among those reported in the literature, and among 22 other patients we have studied. They have inherited HBB haplotype IV/IV associated with XmnI polymorphism in HBG2 promoter, similar to Senegal haplotype found in sickle cell anaemia patients with increased HbF. Fifteen other transfusion-dependent patients also were homozygous for haplotype IV (Table III) . Therefore these findings could not account for the twins' exceptionally mild phenotype.
Genotyping done on skeletal remains of an 8-year old child found in an archaeological site in Israel revealed FSC8 homozygosity (Filon et al, 1995) . The site was dated to the Ottoman period between 16th and 19th centuries. The authors surmised that the child must have had inherently high HbF production to sustain her survival (Filon et al, 1995) .
Stress erythropoiesis and HBG mRNA accumulation and translation
Stress erythropoiesis plays an important role in enhanced HbF production. For example, sickle cell anaemia patients from Eastern Provinces in Saudi Arabia have markedly elevated HbF levels, yet their HbS carrier parents, with the same Arab-Indian haplotype and no haemolysis, have normal HbF (Miller et al, 1986) . The twins had splenomegaly and minimal reticulocytosis consistent with mild stress erythropoiesis.
In studies on the Corfu db-thalassaemia deletion in conjunction with b IVS I-5 G>A (HBB:c.92 + 5G>A), a severe b + -thalassaemia mutation, robust HBG mRNA accumulation and translation resulting in elevated HbF levels occurred only when HBB mRNA fell below a critical threshold (Chakalova et al, 2005) . FSC8 homozygotes have absence of HBB mRNA due to nonsense-mediated decay. This might account for the propensity of all FSC8 homozygotes to produce increased HbF. Alone, this would not explain the twins' asymptomatic phenotype compared with other patients.
Genetic determinants of HbF expression
There are three major HbF QTL, on Chr.11p15, 6q23 and 2p16. Together they account for approximately 20-50% of HbF variance in different populations. However genetic determinants accounting for more than half of HbF variance in all populations are yet to be discovered. The twins were (i) homozygous for HBB haplotype IV; (ii) homozygous for rs7482144 alternate allele on chr.11p15; (iii) homozygous for HMIP 3-bp deletion on chr.6q23; (iv) heterozygous for BCL11A intron 2 QTL on chr.2p16; and (v) heterozygous for Hph a-thalassaemia mutation. These genetic variants must be partially responsible for increased HbF expression in the twins and in other FSC8 homozygotes. Among patients of African descent with sickle cell anaemia, the Senegal haplotype, characterized by rs7482144, have the highest HbF. The twins were homozygous for HBB haplotype IV, which shares six identical and consecutive polymorphisms from HBE to HBBP1 with the Senegal haplotype. The proband has inherited the same purine/pyrimidine repetitive sequence within LCR HS2 as in the Senegal haplotype ( € Oner et al, 1992) , and rs2071348 and rs10128556 within the HBD-HBG1 intergenic region known to be associated with elevated HBG expression (Galarneau et al, 2010; Nuinoon et al, 2010) . There were 3-4 times more HBG2 than HBG1 globin chains in both twins, as predicted by the presence of rs7482144. The pathways whereby haplotype IV   Fig 1. The figure shows~8Á5 kb of BCL11A intron 2 region encompassing the 3 erythroid-specific DHS (Bauer et al, 2013) . The numbers on the first row represent hg19 Chr2 positions (http://hgdownload.cse.ucsc.edu/goldenPath/hg19/bigZips/). On the second and third rows, each perpendicular bar represents a single SNP found in the proband. Red and blue bars represent heterozygosity for the SNP alternate allele. The black bars represent homozygosity for the SNP reference allele. The red bar represents homozygosity for the SNP alternate allele (see Table II ). The green shaded areas represent the 3 DHS, and the numbers on the bottom row represent distances in kb from BCL11A transcription start site (Bauer et al, 2013) . They are DHS +62, Chr2:60 717 492-60 718 860; DHS +58, Chr2:60 721 411-60 722 674; and DHS +55, Chr2:60 724 802-60 726 084. The black areas represent Chip-seq signals of GATA1 in human peripheral blood-derived erythroblasts, from ENCODE data (https://www.encodeproject.org/experiments/ENCSR000EXP/). DHS, DNase 1 hypersensitive site; SNP, single nucleotide polymorphism.
is associated with HbF up-regulation are presently not known.
The most important functional motif for HMIP is the 3-bp deletion, rs66650371 in an enhancer capable of regulating MYB expression (Farrell et al, 2011; Stadhouders et al, 2014) . In the immediate vicinity of the 3-bp deletion polymorphism are binding sites for TAL1, GATA2, and RUNX1. The 3-bp deletion interferes with normal spatial orientation for DNAprotein binding and/or protein-protein interactions, leading to decreased enhancer activity and down-regulation of MYB expression. MYB can transactivate KLF1 expression, and also plays an important role in cellular proliferation and haematopoiesis (Jiang et al, 2006; Menzel et al, 2007b; Ganesh et al, 2009; Bianchi et al, 2010) . Both twins were homozygous for this 3-bp deletion (Tables II and III) . This has to be one of the pivotal genetic determinants accounting for the twin's heightened HbF production.
BCL11A is an essential transcriptional repressor of HBG expression. Both twins were heterozygous for this QTL in BCL11A intron 2. Their mother and sister were homozygous for the same QTL, and yet their HbF levels were merely 4-5% (Table I) . Two patients (7 and 22 in Table SV) were also homozygous for this QTL, and yet they were transfusion dependent. Therefore, BCL11A polymorphisms are not responsible for the twins' exceptionally high HbF.
The twins were heterozygous for a deletion of 5-bp (-TGAGG) in the IVS-1 donor splice site in HBA2 (HBA2: c.95 + 2_95 + 6delTGAGG), the more highly expressed of the two HBAs. In b-thalassaemia patients, the co-inheritance of a-thalassaemia reduces HBA to non-HBA synthetic imbalance, and results in less unpaired HBA that can precipitate and damage the erythroid cell. The inheritance of a-thalassaemia in the twins in conjunction with their HbF QTL alternate alleles should aid in the preferential survival of many more RBC with high HbF expression. Of note is Patient 12 who had single HBA deletion and severe disease phenotype (Table SV) .
To summarize, homozygosity for the 3-bp deletion in HMIP and heterozygosity for the Hph a-thalassaemia mutation in HBA2 were the two genetic determinants found only in the asymptomatic twins and not found in any of the other 22 FSC8 homozygote patients. These two genetic variants are most likely among the essential genetic factors contributing to the twins' uniquely high HbF expression. Future investigations by genetic approaches, such as whole genome sequencing and transcriptome expression, to study and compare FSC8 homozygotes with markedly disparate phenotypes should identify additional genetic variants that are important in regulating HBG expression. 
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Supporting Information
Additional Supporting Information may be found in the online version of this article: Fig S1 . The top figure shows the nucleotide sequences from a normal individual beginning from the HBB initiation codon ATG to codon 13. Codon 8 is AAG. The lower figure shows the nucleotide sequences from the proband. Codon 8 is GTC, as a result of homozygous deletion of dinucleotides AA from the normal codon 8 sequences. Fig S2. MLPA on proband's HBB gene cluster showing equal signal strength of probes from LCR to 9 kb downstream from HBB. Fig S3. The figure shows~14Á5 kb HBG1 -HBD intergenic region. The numbers on the first row represent hg19 Chr11 positions. Each bar represents a single SNP found in the proband, all homozygous for the alternate alleles (Table  SIII) . Also shown are: enhancer 3' to HBG1 (Bodine, Ley, EMBO J 1987; 6:2997-3004) , BGLT3 template for a long non-coding RNA (Kiefer et al, Blood 2011; 118:6200-6208) , Corfu deletion (Kulozik et al, Blood 1988; 71:457-462) , PYR complex DNA-binding site (Bank, Blood 2006; 107:435-443) , and two purported BCL11A binding sites, at 3 kb downstream of HBG1, and 1 kb upstream of HBD (Sankaran et al, N Engl J Med 2011; 365:807-814) . SNP rs10128556 is associated with elevated HbF in sickle cell anemia patients (Galarneau et al, Nat Genet 2010; 42:1049 -1051 . SNP rs2071348 is associated with elevated HbF and milder disease severity in patients with HbE/b 0 -thalassemia (Nuinoon et al, Hum Genet 2010; 127:303-314) . Table SI . ARMS tests to determine HbF QTL genotypes. Table SII . Non-identical SNP genotypes at 7 loci found in two dizygotic twins. Table SIII . 21 SNPs present within proband's HBD to hbg1 intergenic region. Table SIV . FSC8 Homozygotes, with no or rare transfusion. Patients #3 and #4 were sisters. They were originally reported in 1989 by Gurney et al. Patients #6 and #16 (Table  SV) were siblings. SNP alternate alleles are: A for rs7482144, C for rs9399137, del for rs66650371, and C for rs766432. 
